Product image of Linezolid Tad (Linezolid) supplied by GNH India

Linezolid Tad

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Tad (Linezolid)

Linezolid, the active ingredient in Linezolid Tad, is a oxazolidinone antibiotic presented as an oral dosage form for systemic use. It treats infections caused by Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients.

GNH India supplies Linezolid Tad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Tad Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to treat serious Gram‑positive bacterial infections.

  • Complicated skin and soft tissue infections: effective against MRSA and other resistant Gram‑positive pathogens.
  • Community‑acquired and nosocomial pneumonia: provides coverage for resistant Gram‑positive organisms in lung infections.
  • Infections caused by vancomycin‑resistant Enterococcus (VRE): offers an oral treatment option for VRE infections.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, preventing formation of the initiation complex. This action blocks the translation process, halting bacterial growth and leading to a bacteriostatic effect against susceptible Gram‑positive organisms.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe. Monitoring for side effects is recommended during therapy.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools that may be self‑limiting.
  • Headache: transient cranial discomfort.
  • Metallic taste: altered taste perception.
  • Vomiting: occasional emesis.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count requiring monitoring.
  • Anemia: reduced red blood cell levels, potentially leading to fatigue.
  • Peripheral neuropathy: nerve damage presenting as tingling or numbness.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Severe allergic reactions: including anaphylaxis.
  • Optic neuritis: rare inflammation of the optic nerve affecting vision.

Precautions & Warnings

Before initiating Linezolid therapy, consider the following safety measures.

  • Renal impairment: assess renal function and monitor for accumulation.
  • Hepatic impairment: use with caution in patients with liver disease.
  • Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome.
  • Long‑term therapy: regularly monitor complete blood counts.
  • Pregnancy and lactation: evaluate risk versus benefit before prescribing.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Avoid Interactions

Linezolid can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): may precipitate severe serotonin toxicity.
  • Tyramine‑rich foods: potential hypertensive reactions due to MAO inhibition.
  • Rifampin: reduces linezolid plasma concentrations, compromising efficacy.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened bleeding risk.
  • Warfarin: possible alteration of INR, requiring closer monitoring.
  • Anticonvulsants (e.g., carbamazepine): may affect linezolid metabolism.
  • Oral contraceptives: potential reduction in effectiveness, advise alternative contraception.

Frequently Asked Questions

Linezolid Tad is indicated for serious infections caused by Gram‑positive bacteria, such as skin and soft tissue infections, community‑acquired or hospital‑acquired pneumonia, and infections due to vancomycin‑resistant Enterococcus. It is effective against resistant organisms like MRSA and VRE.

Linezolid inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit. This prevents the formation of the initiation complex required for translation, resulting in a bacteriostatic effect that stops bacterial growth.

The dosage of Linezolid Tad is determined by the prescribing clinician based on the specific infection, patient weight, renal and hepatic function, and other clinical factors. The prescriber will set the appropriate regimen.

Safety of Linezolid Tad in pregnancy and lactation has not been fully established. Clinicians should weigh the potential benefits against possible risks and consider alternative therapies when appropriate.

To order Linezolid Tad, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Linezolid offers oral administration and activity against MRSA, whereas many alternatives such as vancomycin require intravenous infusion. Its unique mechanism provides coverage for resistant Gram‑positive organisms, but clinicians consider factors like side‑effect profile, drug interactions, and patient-specific circumstances when selecting therapy.

Linezolid Tad should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and ensure the container is tightly closed to maintain stability.

Linezolid Tad is taken orally, usually as a tablet or oral suspension, depending on the formulation supplied. It should be swallowed whole with water, and dosing intervals are defined by the prescribing clinician.

Serious risks include thrombocytopenia, anemia, peripheral neuropathy, serotonin syndrome when combined with serotonergic agents, and rare optic neuritis. Patients should be monitored regularly for blood‑count changes and neurological symptoms during treatment.

Linezolid Tad is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation. Caution is advised for individuals taking serotonergic drugs, MAO inhibitors, or those with uncontrolled hypertension due to potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT